Etodolac/Lidocaine

依托度酸/利多卡因

Report date: 2026/02/13 10:40:22

Base Information

Drug NameEtodolac/Lidocaine
Drug Alias NameEtodolac and Lidocaine利多卡因/依托度酸Lidocaine and EtodolacLidocaine/EtodolacMRX-7EAT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitorsSodium channel alpha subunit modulators
TargetsSodium channel alpha subunitCyclooxygenases
Therapy Area/IndicationsLow Back PainTendinopathyMyalgia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes EtodolacLidocaine
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedrx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedrx Usa Inc
Active IndicationsN/A
Inactive IndicationsLow Back PainTendinopathyMyalgia +[5] 

Other Information

ATC CodeN/A
Related LinksN/A